| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S12094-008-0235-4 |
| P698 | PubMed publication ID | 18667377 |
| P2093 | author name string | Benilde Jiménez | |
| Beatriz Martínez-Poveda | |||
| José L Orgaz | |||
| Nuria I Fernández-García | |||
| P2860 | cites work | HSulf-1 inhibits angiogenesis and tumorigenesis in vivo | Q24293660 |
| Imaging in the era of molecular oncology | Q24650949 | ||
| Tumor angiogenesis: therapeutic implications | Q27860595 | ||
| Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein | Q27861056 | ||
| Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth | Q28203327 | ||
| Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis | Q28264314 | ||
| Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial | Q28268831 | ||
| Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy | Q29547379 | ||
| The importance of tumor angiogenesis: the evidence continues to grow | Q80878691 | ||
| Circulating endothelial cells. Biomarker of vascular disease | Q81402646 | ||
| IB05204, a dichloropyridodithienotriazine, inhibits angiogenesis in vitro and in vivo | Q81444715 | ||
| Potential involvement of the cyclooxygenase-2 pathway in the regulation of tumor-associated angiogenesis and growth in pancreatic cancer | Q95795654 | ||
| Molecular regulation of vessel maturation | Q29614540 | ||
| Angiogenesis in health and disease | Q29614541 | ||
| Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability | Q29617252 | ||
| Mechanisms of angiogenesis and arteriogenesis | Q29617257 | ||
| Tumorigenesis and the angiogenic switch | Q29619849 | ||
| AZD2171, a pan-VEGF receptor tyrosine kinase inhibitor, normalizes tumor vasculature and alleviates edema in glioblastoma patients. | Q30490422 | ||
| Tracking angiogenesis induced by skin wounding and contact hypersensitivity using a Vegfr2-luciferase transgenic mouse | Q31002708 | ||
| Imaging of angiogenesis: from microscope to clinic | Q31144032 | ||
| Clinical significance of determination of surrogate markers of angiogenesis in breast cancer | Q31884454 | ||
| VEGFs, receptors and angiogenesis | Q33644265 | ||
| Angiogenesis in epithelian ovarian cancer | Q33919078 | ||
| Angiogenesis assays: problems and pitfalls | Q34146311 | ||
| Mechanistic insights on the inhibition of tumor angiogenesis. | Q34297680 | ||
| The chick embryo chorioallantoic membrane as a model for in vivo research on anti-angiogenesis | Q34316079 | ||
| The prognostic role of angiogenesis in breast cancer. | Q34573910 | ||
| The prognostic molecular markers in hepatocellular carcinoma | Q34668320 | ||
| Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us. | Q34693504 | ||
| Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy? | Q34988256 | ||
| Angiogenesis assays: a critical overview | Q35036728 | ||
| Vascular endothelial growth factor in colorectal cancer | Q35681811 | ||
| Quantitative Assessment of Angiogenic Responses by the Directed in Vivo Angiogenesis Assay | Q35749086 | ||
| Modelling approaches for angiogenesis | Q35761439 | ||
| Current methods for assaying angiogenesis in vitro and in vivo. | Q35893291 | ||
| Imaging tumor angiogenesis with fluorescent proteins | Q35962612 | ||
| Imaging angiogenesis: applications and potential for drug development | Q36027611 | ||
| Transforming growth factor-beta 1 modulates basic fibroblast growth factor-induced proteolytic and angiogenic properties of endothelial cells in vitro | Q36223450 | ||
| VEGF as a therapeutic target in cancer | Q36319029 | ||
| In vivo models of angiogenesis | Q36600421 | ||
| Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer | Q36613812 | ||
| Yeast-derived beta-glucan augments the therapeutic efficacy mediated by anti-vascular endothelial growth factor monoclonal antibody in human carcinoma xenograft models | Q36672598 | ||
| Genetic determinants of cancer metastasis | Q36794312 | ||
| VEGF-targeted cancer therapy strategies: current progress, hurdles and future prospects | Q36803200 | ||
| Drug insight: advances in renal cell carcinoma and the role of targeted therapies | Q36893554 | ||
| Molecular and cellular biomarkers for angiogenesis in clinical oncology | Q36969648 | ||
| Lessons from multidisciplinary translational trials on anti-angiogenic therapy of cancer | Q37109214 | ||
| Non-invasive assessment of tumor neovasculature: techniques and clinical applications | Q37174460 | ||
| The chick embryo chorioallantoic membrane in the study of tumor angiogenesis. | Q37178923 | ||
| A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood | Q37201827 | ||
| Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer | Q37219981 | ||
| Modulation of the antitumor activity of metronomic cyclophosphamide by the angiogenesis inhibitor axitinib | Q38568650 | ||
| The tumour-stromal interaction between intratumoral c-Met and stromal hepatocyte growth factor associated with tumour growth and prognosis in non-small-cell lung cancer patients | Q38798344 | ||
| An antibody directed against PDGF receptor beta enhances the antitumor and the anti-angiogenic activities of an anti-VEGF receptor 2 antibody | Q40140583 | ||
| Circulating endothelial progenitor cells correlate to stage in patients with invasive breast cancer | Q40149456 | ||
| Blood-based biomarkers of SU11248 activity and clinical outcome in patients with metastatic imatinib-resistant gastrointestinal stromal tumor. | Q40217269 | ||
| Inhibition of in vivo angiogenesis by N-beta-alanyl-5-S-glutathionyl-3,4-dihydroxyphenylalanine | Q40275281 | ||
| Nestin-linked green fluorescent protein transgenic nude mouse for imaging human tumor angiogenesis | Q40408928 | ||
| Continuous infusion of endostatin inhibits differentiation, mobilization, and clonogenic potential of endothelial cell progenitors. | Q40609424 | ||
| Human vascular endothelial cells with extended life spans: in vitro cell response, protein expression, and angiogenesis | Q40674897 | ||
| Quantitative angiogenesis assays: progress and problems | Q41634715 | ||
| Human microvascular endothelial cells differ from macrovascular endothelial cells in their expression of matrix metalloproteinases | Q42449747 | ||
| Paracrine induction of angiogenesis in vitro by Swiss 3T3 fibroblasts | Q42807841 | ||
| Angiogenic sprouting and capillary lumen formation modeled by human umbilical vein endothelial cells (HUVEC) in fibrin gels: the role of fibroblasts and Angiopoietin-1. | Q43793256 | ||
| Quantification of anti-angiogenesis using the capillaries of the chick chorioallantoic membrane demonstrates that the effect of human angiostatin is age-dependent | Q44799510 | ||
| Noninvasive indirect imaging of vascular endothelial growth factor gene expression using bioluminescence imaging in living transgenic mice | Q46169454 | ||
| Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients | Q46781791 | ||
| The mouse cornea micropocket angiogenesis assay | Q46941937 | ||
| Basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF) levels, as prognostic indicators in NSCLC. | Q47955121 | ||
| Bioluminescence imaging of vascular endothelial growth factor promoter activity in murine mammary tumorigenesis | Q48017638 | ||
| A transgenic Tie2-GFP athymic mouse model; a tool for vascular biology in xenograft tumors. | Q50648099 | ||
| Bright far-red fluorescent protein for whole-body imaging. | Q50681538 | ||
| Universal GFP reporter for the study of vascular development. | Q52163301 | ||
| Antiangiogenic effect of bile acid acylated heparin derivative. | Q53584662 | ||
| Tumor Growth and Neovascularization: An Experimental Model Using the Rabbit Cornea 2 | Q53810509 | ||
| Angiogenic activity of human chorionic gonadotropin through LH receptor activation on endothelial and epithelial cells of the endometrium. | Q54574501 | ||
| Molecular co-expression of the c-Met oncogene and hepatocyte growth factor in primary colon cancer predicts tumor stage and clinical outcome. | Q54584505 | ||
| Mobilization of capillary endothelium in vitro induced by effectors of angiogenesis in vivo. | Q55062382 | ||
| Serum Soluble Vascular Cell Adhesion Molecule-1: Role as a Surrogate Marker of Angiogenesis | Q59289072 | ||
| Characterization and clinical relevance of circulating and biopsy-derived endothelial progenitor cells in lymphoma patients | Q61787495 | ||
| A simple procedure for the long-term cultivation of chicken embryos | Q68879935 | ||
| Assay of capillary endothelial cell migration | Q69429370 | ||
| Induction of morphologic differentiation of endothelial cells in culture | Q69667139 | ||
| Differentiation of vascular endothelium in the chick chorioallantois: A structural and autoradiographic study | Q69770576 | ||
| A novel, microcarrier-based in vitro assay for rapid and reliable quantification of three-dimensional cell migration and angiogenesis | Q70957426 | ||
| Rat aortic smooth muscle cells become pericytes during angiogenesis in vitro | Q71518478 | ||
| A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration | Q72133316 | ||
| Circulating endothelial cells as a novel marker of angiogenesis | Q73212055 | ||
| Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1 | Q73308215 | ||
| Evaluation of soluble intracellular adhesion molecule-1 (sICAM-1) in benign and malignant ovarian masses | Q73526754 | ||
| Soluble FLT-1 is detectable in the sera of colorectal and breast cancer patients | Q74591474 | ||
| Tumor induction of VEGF promoter activity in stromal cells | Q77349243 | ||
| Angiogenesis in multiple myeloma | Q79783383 | ||
| Increased levels of circulating endothelial progenitor cells and circulating endothelial nitric oxide synthase in patients with gliomas | Q80338347 | ||
| Utilization of bone marrow-derived endothelial cell precursors in spontaneous prostate tumors varies with tumor grade | Q80516695 | ||
| Elevated circulating endothelial progenitor marker CD133 messenger RNA levels predict colon cancer recurrence | Q80534318 | ||
| P433 | issue | 8 | |
| P921 | main subject | tumor angiogenesis | Q110495869 |
| angiogenesis | Q539568 | ||
| P304 | page(s) | 468-477 | |
| P577 | publication date | 2008-08-01 | |
| P1433 | published in | Clinical and Translational Oncology | Q15754324 |
| P1476 | title | Following up tumour angiogenesis: from the basic laboratory to the clinic | |
| P478 | volume | 10 |
| Q89219479 | Correlation Between Contrast-enhanced Ultrasound Characteristics (Qualitative and Quantitative) and Pathological Prognostic Factors in Breast Cancer |
| Q34121796 | The 5-HT(2B) receptor plays a key regulatory role in both neuroendocrine tumor cell proliferation and the modulation of the fibroblast component of the neoplastic microenvironment |
| Q39891635 | c-Met-targeted RNA interference inhibits growth and metastasis of glioma U251 cells in vitro |
Search more.